{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:08Z","timestamp":1786119128590,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,30]]},"DOI":"10.1097\/qad.0b013e3282f5e07a","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T12:52:13Z","timestamp":1236257533000},"page":"717-725","source":"Crossref","is-referenced-by-count":20,"title":["Sequence editing by Apolipoprotein B RNA-editing catalytic component-B and epidemiological surveillance of transmitted HIV-1 drug resistance"],"prefix":"10.1097","volume":"22","author":[{"given":"Robert J","family":"Gifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Yon","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy F","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar K","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/JVI.65.4.1779-1788.1991","article-title":"Selection, recombination, and G\u2013A hypermutation of human immunodeficiency virus type 1 genomes","volume":"65","author":"Vartanian","year":"1991","journal-title":"J Virol"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1128\/JVI.75.17.7973-7986.2001","article-title":"Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells","volume":"75","author":"Janini","year":"2001","journal-title":"J Virol"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/088922203771881211","article-title":"Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection","volume":"19","author":"Koulinska","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.79.3.1975-1980.2005","article-title":"G \u2192 A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo","volume":"79","author":"Kieffer","year":"2005","journal-title":"J Virol"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1128\/JVI.80.3.1067-1076.2006","article-title":"Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors","volume":"80","author":"Cullen","year":"2006","journal-title":"J Virol"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tibs.2007.01.004","article-title":"APOBEC-mediated viral restriction: not simply editing?","volume":"32","author":"Holmes","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat Med"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.ppat.0010006","article-title":"Natural variation in Vif: differential impact on APOBEC3G\/3F and a potential role in HIV-1 diversification","volume":"1","author":"Simon","year":"2005","journal-title":"PLoS Pathog"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1097\/00002030-200409030-00022","article-title":"APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations","volume":"18","author":"Berkhout","year":"2004","journal-title":"AIDS"},{"key":"R10-6-20210130","first-page":"148","article-title":"Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance","volume":"8","author":"Hache","year":"2006","journal-title":"AIDS Rev"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1093\/nar\/gkl555","article-title":"Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication","volume":"34","author":"Suspene","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1371\/journal.pbio.0020275","article-title":"Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G","volume":"2","author":"Sawyer","year":"2004","journal-title":"PLoS Biol"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/bioinformatics\/16.4.400","article-title":"Detecting hypermutations in viral sequences with an emphasis on G \u2192 A hypermutation","volume":"16","author":"Rose","year":"2000","journal-title":"Bioinformatics"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.1128\/JVI.00888-06","article-title":"Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation","volume":"80","author":"Pace","year":"2006","journal-title":"J Virol"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1093\/bioinformatics\/bti569","article-title":"A statistical model for HIV-1 sequence classification using the subtype analyser (STAR)","volume":"21","author":"Myers","year":"2005","journal-title":"Bioinformatics"},{"key":"R18-6-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","article-title":"HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance","volume":"21","author":"Shafer","year":"2007","journal-title":"AIDS"},{"key":"R19-6-20210130","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","article-title":"ROCR: visualizing classifier performance in R","volume":"21","author":"Sing","year":"2005","journal-title":"Bioinformatics"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1074\/jbc.M500382200","article-title":"The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain","volume":"280","author":"Hache","year":"2005","journal-title":"J Biol Chem"},{"key":"R21-6-20210130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.cub.2004.06.057","article-title":"Cytidine deamination of retroviral DNA by diverse APOBEC proteins","volume":"14","author":"Bishop","year":"2004","journal-title":"Curr Biol"},{"key":"R22-6-20210130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jmb.2004.01.046","article-title":"Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo","volume":"337","author":"Beale","year":"2004","journal-title":"J Mol Biol"},{"key":"R24-6-20210130","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/01.aids.0000131394.76221.02","article-title":"Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure","volume":"18","author":"Ceccherini-Silberstein","year":"2004","journal-title":"AIDS"},{"key":"R25-6-20210130","doi-asserted-by":"crossref","first-page":"10718","DOI":"10.1128\/JVI.79.16.10718-10729.2005","article-title":"High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations","volume":"79","author":"Ceccherini-Silberstein","year":"2005","journal-title":"J Virol"},{"key":"R26-6-20210130","doi-asserted-by":"crossref","first-page":"26726","DOI":"10.1074\/jbc.M314038200","article-title":"Purifying selection masks the mutational flexibility of HIV-1 reverse transcriptase","volume":"279","author":"Smith","year":"2004","journal-title":"J Biol Chem"},{"key":"R27-6-20210130","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/00002030-200209060-00015","article-title":"Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants","volume":"16","author":"Dowling","year":"2002","journal-title":"AIDS"},{"key":"R28-6-20210130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1089\/088922202320886325","article-title":"Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate","volume":"18","author":"Harris","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R29-6-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.qai.0000226793.16216.55","article-title":"Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon","volume":"43","author":"Koizumi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-6-20210130","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1089\/08892220152644250","article-title":"Phylogenetic analysis of reverse transcriptase in antiretroviral drug-naive Korean HIV type 1 patients","volume":"17","author":"Sung","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R31-6-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/088922204323087705","article-title":"The changing molecular epidemiology of HIV type 1 among northern Thai drug users 1999 to 2002","volume":"20","author":"Tovanabutra","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R32-6-20210130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/088922203322493111","article-title":"HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs","volume":"19","author":"Lan","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R33-6-20210130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jviromet.2006.04.009","article-title":"Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes","volume":"136","author":"Rousseau","year":"2006","journal-title":"J Virol Methods"},{"key":"R34-6-20210130","first-page":"570","article-title":"Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan","volume":"39","author":"Carr","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-6-20210130","first-page":"119","article-title":"Update of the drug resistance mutations in HIV-1: 2007","volume":"15","author":"Johnson","year":"2007","journal-title":"Top HIV Med"},{"key":"R36-6-20210130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/431199","article-title":"Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature","volume":"41","author":"Ivers","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R37-6-20210130","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa051908","article-title":"Antiretroviral therapy in a thousand patients with AIDS in Haiti","volume":"353","author":"Severe","year":"2005","journal-title":"N Engl J Med"},{"key":"R38-6-20210130","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.aids.0000226959.87471.01","article-title":"Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study","volume":"20","author":"Etard","year":"2006","journal-title":"AIDS"},{"key":"R39-6-20210130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":"Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"R40-6-20210130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"Gilks","year":"2006","journal-title":"Lancet"},{"key":"R41-6-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200501030-00001","article-title":"The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models","volume":"19","author":"Blower","year":"2005","journal-title":"AIDS"},{"key":"R44-6-20210130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QCO.0b013e3280109ff1","article-title":"The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world","volume":"19","author":"Bennett","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"R45-6-20210130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JCM.02016-06","article-title":"Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing","volume":"45","author":"McNulty","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R46-6-20210130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/135965350701200114","article-title":"HIV-1 drug resistance surveillance using dried whole blood spots","volume":"12","author":"Bertagnolio","year":"2007","journal-title":"Antivir Ther"},{"key":"R47-6-20210130","doi-asserted-by":"crossref","first-page":"13050","DOI":"10.1128\/JVI.00889-07","article-title":"Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1","volume":"81","author":"Gifford","year":"2007","journal-title":"J Virol"},{"key":"R48-6-20210130","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1073\/pnas.0407534102","article-title":"Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups","volume":"102","author":"Hue","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R49-6-20210130","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/444836a","article-title":"Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak","volume":"444","author":"de Oliveira","year":"2006","journal-title":"Nature"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200803300-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:49:27Z","timestamp":1786038567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200803300-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,30]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282f5e07a","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3,30]]}}}